177 related articles for article (PubMed ID: 17367917)
1. Impact of multimodal treatment on survival in patients with metastatic urothelial cancer.
Abe T; Shinohara N; Harabayashi T; Sazawa A; Maruyama S; Suzuki S; Nonomura K
Eur Urol; 2007 Oct; 52(4):1106-13. PubMed ID: 17367917
[TBL] [Abstract][Full Text] [Related]
2. Editorial comment on: Impact of multimodal treatment on survival in patients with metastatic urothelial cancer.
Bamias A
Eur Urol; 2007 Oct; 52(4):1113-4. PubMed ID: 17367916
[No Abstract] [Full Text] [Related]
3. Outcome of metastatic urothelial carcinoma treated by systemic chemotherapy: Prognostic factors based on real-world clinical practice in Japan.
Abe T; Ishizaki J; Kikuchi H; Minami K; Matsumoto R; Harabayashi T; Sazawa A; Mochizuki T; Chiba S; Akino T; Murakumo M; Miyajima N; Tsuchiya K; Maruyama S; Murai S; Shinohara N
Urol Oncol; 2017 Feb; 35(2):38.e1-38.e8. PubMed ID: 27693091
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors for metastatic urothelial carcinoma treated with cisplatin and 5-fluorouracil-based regimens.
Lin CC; Hsu CH; Huang CY; Tsai YC; Huang KH; Cheng AL; Pu YS
Urology; 2007 Mar; 69(3):479-84. PubMed ID: 17382149
[TBL] [Abstract][Full Text] [Related]
5. Is there a role for pulmonary metastasectomy with a curative intent in patients with metastatic urinary transitional cell carcinoma?
Matsuguma H; Yoshino I; Ito H; Goya T; Matsui Y; Nakajima J; Ikeda N; Okumura S; Shiono S; Nomori H;
Ann Thorac Surg; 2011 Aug; 92(2):449-53. PubMed ID: 21801905
[TBL] [Abstract][Full Text] [Related]
6. Long-term survival and prognostic factors in patients with metastatic gastric cancers treated with chemotherapy in the Japan Clinical Oncology Group (JCOG) study.
Yoshida M; Ohtsu A; Boku N; Miyata Y; Shirao K; Shimada Y; Hyodo I; Koizumi W; Kurihara M; Yoshida S; Yamamoto S
Jpn J Clin Oncol; 2004 Nov; 34(11):654-9. PubMed ID: 15613554
[TBL] [Abstract][Full Text] [Related]
7. Predictive factors for response and prognostic factors for long-term survival in consecutive, single institution patients with locally advanced and/or metastatic transitional cell carcinoma following cisplatin-based chemotherapy.
Jessen C; Agerbaek M; Von Der Maase H
Acta Oncol; 2009; 48(3):411-7. PubMed ID: 18798018
[TBL] [Abstract][Full Text] [Related]
8. Clinical course of breast cancer patients with metastases limited to the liver treated with chemotherapy.
Er O; Frye DK; Kau SW; Broglio K; Valero V; Hortobagyi GN; Arun B
Cancer J; 2008; 14(1):62-8. PubMed ID: 18303485
[TBL] [Abstract][Full Text] [Related]
9. No role of adjuvant systemic therapy after complete metastasectomy in metastatic renal cell carcinoma?
Kwak C; Park YH; Jeong CW; Lee SE; Ku JH
Urol Oncol; 2007; 25(4):310-6. PubMed ID: 17628297
[TBL] [Abstract][Full Text] [Related]
10. Perioperative chemotherapy in patients undergoing pulmonary resection for metastatic soft-tissue sarcoma of the extremity : a retrospective analysis.
Canter RJ; Qin LX; Downey RJ; Brennan MF; Singer S; Maki RG
Cancer; 2007 Nov; 110(9):2050-60. PubMed ID: 17828771
[TBL] [Abstract][Full Text] [Related]
11. Metastasectomy without systemic therapy in metastatic renal cell carcinoma: comparison with conservative treatment.
Kwak C; Park YH; Jeong CW; Lee SE; Ku JH
Urol Int; 2007; 79(2):145-51. PubMed ID: 17851285
[TBL] [Abstract][Full Text] [Related]
12. Survival impact of integrative cancer care in advanced metastatic breast cancer.
Block KI; Gyllenhaal C; Tripathy D; Freels S; Mead MN; Block PB; Steinmann WC; Newman RA; Shoham J
Breast J; 2009; 15(4):357-66. PubMed ID: 19470134
[TBL] [Abstract][Full Text] [Related]
13. [Metastatic nasopharyngeal carcinoma: clinical study and therapeutic results of 95 cases].
Khanfir A; Frikha M; Ghorbel A; Karray H; Drira MM; Daoud J
Cancer Radiother; 2006 Dec; 10(8):545-9. PubMed ID: 16807035
[TBL] [Abstract][Full Text] [Related]
14. Impact of adjuvant systemic chemotherapy on postoperative survival in patients with high-risk urothelial cancer.
Suzuki S; Shinohara N; Harabayashi T; Sato S; Abe T; Koyanagi T
Int J Urol; 2004 Jul; 11(7):456-60. PubMed ID: 15242352
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors and role of salvage surgery in chemorefractory ovarian germ cell malignancies: a study in Chinese patients.
Li J; Yang W; Wu X
Gynecol Oncol; 2007 Jun; 105(3):769-75. PubMed ID: 17459461
[TBL] [Abstract][Full Text] [Related]
16. A 25-year single institution experience with surgery for primary mediastinal nonseminomatous germ cell tumors.
Kesler KA; Rieger KM; Hammoud ZT; Kruter LE; Perkins SM; Turrentine MW; Schneider BP; Einhorn LH; Brown JW
Ann Thorac Surg; 2008 Feb; 85(2):371-8. PubMed ID: 18222228
[TBL] [Abstract][Full Text] [Related]
17. Brain metastases in breast cancer: prognostic factors and management.
Lee SS; Ahn JH; Kim MK; Sym SJ; Gong G; Ahn SD; Kim SB; Kim WK
Breast Cancer Res Treat; 2008 Oct; 111(3):523-30. PubMed ID: 17990100
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery.
Caglar HB; Baldini EH; Othus M; Rabin MS; Bueno R; Sugarbaker DJ; Mentzer SJ; Jänne PA; Johnson BE; Allen AM
Cancer; 2009 Sep; 115(18):4156-66. PubMed ID: 19551884
[TBL] [Abstract][Full Text] [Related]
19. Palliative chemotherapy in elderly patients with common metastatic malignancies: A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictors.
Pentheroudakis G; Fountzilas G; Kalofonos HP; Golfinopoulos V; Aravantinos G; Bafaloukos D; Papakostas P; Pectasides D; Christodoulou C; Syrigos K; Economopoulos T; Pavlidis N;
Crit Rev Oncol Hematol; 2008 Jun; 66(3):237-47. PubMed ID: 18243010
[TBL] [Abstract][Full Text] [Related]
20. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.
Saito K; Kawakami S; Fujii Y; Sakura M; Masuda H; Kihara K
J Urol; 2007 Dec; 178(6):2291-6; discussion 2296. PubMed ID: 17936818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
